Cheng, S.-W.; Chen, P.-C.; Lin, M.-H.; Ger, T.-R.; Chiu, H.-W.; Lin, Y.-F.
GBP5 Repression Suppresses the Metastatic Potential and PD-L1 Expression in Triple-Negative Breast Cancer. Biomedicines 2021, 9, 371.
https://doi.org/10.3390/biomedicines9040371
AMA Style
Cheng S-W, Chen P-C, Lin M-H, Ger T-R, Chiu H-W, Lin Y-F.
GBP5 Repression Suppresses the Metastatic Potential and PD-L1 Expression in Triple-Negative Breast Cancer. Biomedicines. 2021; 9(4):371.
https://doi.org/10.3390/biomedicines9040371
Chicago/Turabian Style
Cheng, Shun-Wen, Po-Chih Chen, Min-Hsuan Lin, Tzong-Rong Ger, Hui-Wen Chiu, and Yuan-Feng Lin.
2021. "GBP5 Repression Suppresses the Metastatic Potential and PD-L1 Expression in Triple-Negative Breast Cancer" Biomedicines 9, no. 4: 371.
https://doi.org/10.3390/biomedicines9040371
APA Style
Cheng, S.-W., Chen, P.-C., Lin, M.-H., Ger, T.-R., Chiu, H.-W., & Lin, Y.-F.
(2021). GBP5 Repression Suppresses the Metastatic Potential and PD-L1 Expression in Triple-Negative Breast Cancer. Biomedicines, 9(4), 371.
https://doi.org/10.3390/biomedicines9040371